deltatrials
Completed NA NCT00960830

Mirtazapine Reduces ICD Shocks in ICD Patients With Depression and Anxiety

Mirtazapine Reduces ICD Appropriate Shocks in Cardioverter Implanted Patients With Depression and Anxiety

Sponsor: Universidad Nacional de Rosario

Conditions Anxiety Depression
Interventions mirtazapine
Updated 6 times since 2017 Last updated: Aug 17, 2009 Started: Apr 30, 2007 Primary completion: Apr 30, 2008 Completion: Nov 30, 2008

Listed as NCT00960830, this NA trial focuses on Anxiety and Depression and remains completed. Sponsored by Universidad Nacional de Rosario, it has been updated 6 times since 2007, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  5. Jun 2018 — Jan 2021 [monthly]

    Completed NA

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Apr 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Universidad Nacional de Rosario
Data source: Universidad Nacional de Rosario

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • San Nicolás, Argentina